Indeed, dysregulated DNA methylation is characteristic of AML [98], and mutations in the TET protein family (e.g., TET2) and DNA methyl transferase proteins (e.g., DNMT3A) are common in AML. This evidence concerns the gene DNMT3A and acute myeloid leukemia.